Krishna Illa News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Krishna illa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Krishna Illa Today - Breaking & Trending Today
Representatives from seven vaccine makers Serum Institute of India, Bharat Biotech, Dr Reddy s Laboratories, Zydus Cadila, Biological E, Gennova Biopharma and Panacea Biotech participated in the meeting.
Loading the player. Foreign banks, capital from abroad can remedy India s bad debt: Abhijit Banerjee As discussion continues whether private players should be allowed in the Indian banking space, Nobel laureate Abhijit Banerjee pointed out how foreign participation can save the bleeding sector. Banerjee said that Indian banks need a huge capital infusion to stay viable that can come easily from foreign sources. Banerjee noted that once we take on the view that the banking sector needs more private ownership, restricting it to Indian ownership will be a mistake. Average time spent on smartphone up 25% to almost 7 hours amid pandemic: Vivo report ....
COVID-19 vaccine: Covaxin is safe, developed on time-proven tech, says Bharat Biotech MD An expert committee of the Central Drugs Standard Control Organisation (CDSCO) sought additional safety and efficacy data for COVID-19 vaccine candidates of Bharat Biotech after deliberating upon its applications seeking emergency use authorisation for the shots BusinessToday.In | December 13, 2020 | Updated 15:58 IST Covaxin has been developed in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV) India s first indigenous coronavirus vaccine, Covaxin, is safe and built on a time-proven technology, claimed Bharat Biotech s chairman and managing director Krishna Illa. Bharat Biotech, which is conducting a Phase-3 clinical trial of Covaxin in over 25 centres across India, applied to the drug regulator seeking emergency authorisation for its COVID-19 vaccine last week based on Phase 1 and 2 trial data. ....